Medicine and Dentistry
Exotropia
100%
Quality of Life
65%
Strabismus
59%
Visual Acuity
55%
Amblyopia
49%
Pediatrics
40%
Retinopathy of Prematurity
32%
Randomized Clinical Trial
31%
Strabismus Surgery
24%
Esotropia
22%
Diplopia
22%
Abducens Nerve Paralysis
19%
Deterioration
18%
Adult Strabismus
16%
Symptom
15%
Exodeviation
12%
Amblyopia Treatment
12%
Surgery
11%
Retinopathy
11%
Nerve Paralysis
10%
Carbon Dioxide
10%
Test Retest Reliability
9%
Cataract
9%
Stereoscopic Vision
9%
Refractive Error
9%
Toddlers
8%
Low Drug Dose
8%
Vascularity
8%
Prevalence
8%
Eye Disease
7%
Group Therapy
7%
Medial Rectus Muscle
7%
Patient-Reported Outcome
7%
Bevacizumab
6%
Fourth Nerve Palsy
6%
Botulinum Toxin
6%
Acidosis
6%
Suture Material
6%
Paralysis
6%
Apyrase
5%
Cranial Nerve Paralysis
5%
Glaucoma
5%
Cataract Surgery
5%
Anisometropia
5%
Rasch Analysis
5%
Oxygen-Induced Retinopathy
5%
Diabetic Retinopathy
5%
Lateral Rectus Muscle
5%
Clinical Trial
5%
Hyperopia
5%
Keyphrases
Intermittent Exotropia
66%
Amblyopia
51%
Visual Acuity
31%
Health-related Quality of Life
28%
Amblyopia Treatment
28%
Randomized Trial
26%
Atropine
25%
Strabismus
23%
Retinopathy of Prematurity
21%
Confidence Interval
20%
Stereoacuity
20%
Randomized Clinical Trial
19%
Anisometropic Amblyopia
19%
Pediatric Eye
18%
Retinopathy
17%
Diplopia
16%
Functional Vision
15%
Adult Strabismus
14%
Sixth Nerve Palsy
13%
Neovascularization
13%
Related Quality of Life
12%
Acidosis
11%
Treatment Study
11%
Esotropia
10%
Oxygen-induced Retinopathy
10%
Strabismus Surgery
10%
Alternate Cover Test
9%
Neonatal Rats
9%
Acuity
9%
Exodeviation
9%
Near Stereoacuity
9%
Quality of Life
9%
Prism Diopter
8%
Eye Conditions
8%
Sixth Nerve Paresis
8%
Control Score
8%
Patient-derived
8%
Rasch Analysis
7%
Clinical Trials
7%
Quality of Life Questionnaire
7%
Part-time Patching
7%
Distance Stereoacuity
7%
Life Concerns
7%
Spontaneous Recovery
6%
Population-based Study
6%
Rat Model
6%
Adult-onset
6%
Dissociated Vertical Deviation
6%
Patient-Reported Outcomes Measurement Information System (PROMIS)
6%
Rasch
6%